Cornelis Van't Veer

Title: Innovations in Thrombosis Prophylaxis by Cornelis Van't Veer

Introduction

Cornelis Van't Veer is a notable inventor based in Burlington, VT (US). He has made significant contributions to the field of thrombosis prophylaxis, particularly for individuals with the Factor V Leiden mutation. With a total of 2 patents, his work focuses on innovative methods to reduce the risk of thrombosis in susceptible populations.

Latest Patents

Cornelis Van't Veer's latest patents include groundbreaking methods for thrombosis prophylaxis for Factor V Leiden carriers. His research indicates that individuals with the Factor V Leiden mutation and lower than average plasma levels of tissue factor pathway inhibitor (TFPI) are at an elevated risk of thrombosis. The prophylactic methods he developed involve the administration of TFPI to achieve higher plasma levels, thereby reducing the risk of thrombosis.

Career Highlights

Cornelis Van't Veer is affiliated with the University of Vermont and State Agricultural College, where he continues to advance research in thrombosis and related fields. His work has garnered attention for its potential to improve patient outcomes and enhance understanding of thrombosis risk factors.

Collaborations

Some of his notable coworkers include Michael Kalafatis and Kenneth G Mann, who have collaborated with him on various research projects aimed at improving thrombosis prophylaxis.

Conclusion

Cornelis Van't Veer's innovative work in thrombosis prophylaxis represents a significant advancement in medical research. His contributions are vital for improving the health and safety of individuals at risk of thrombosis.